1. Home
  2. STOK vs MCBS Comparison

STOK vs MCBS Comparison

Compare STOK & MCBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STOK
  • MCBS
  • Stock Information
  • Founded
  • STOK 2014
  • MCBS 2006
  • Country
  • STOK United States
  • MCBS United States
  • Employees
  • STOK N/A
  • MCBS N/A
  • Industry
  • STOK Biotechnology: Pharmaceutical Preparations
  • MCBS Major Banks
  • Sector
  • STOK Health Care
  • MCBS Finance
  • Exchange
  • STOK Nasdaq
  • MCBS Nasdaq
  • Market Cap
  • STOK 740.9M
  • MCBS 739.2M
  • IPO Year
  • STOK 2019
  • MCBS 2019
  • Fundamental
  • Price
  • STOK $12.87
  • MCBS $27.99
  • Analyst Decision
  • STOK Strong Buy
  • MCBS Hold
  • Analyst Count
  • STOK 5
  • MCBS 1
  • Target Price
  • STOK $27.75
  • MCBS $34.00
  • AVG Volume (30 Days)
  • STOK 763.5K
  • MCBS 36.3K
  • Earning Date
  • STOK 08-06-2025
  • MCBS 07-18-2025
  • Dividend Yield
  • STOK N/A
  • MCBS 3.23%
  • EPS Growth
  • STOK N/A
  • MCBS 20.64
  • EPS
  • STOK 0.88
  • MCBS 2.57
  • Revenue
  • STOK $190,908,000.00
  • MCBS $145,158,000.00
  • Revenue This Year
  • STOK $378.84
  • MCBS $16.00
  • Revenue Next Year
  • STOK N/A
  • MCBS $31.75
  • P/E Ratio
  • STOK $14.68
  • MCBS $11.07
  • Revenue Growth
  • STOK 2333.81
  • MCBS 14.81
  • 52 Week Low
  • STOK $5.35
  • MCBS $24.24
  • 52 Week High
  • STOK $16.15
  • MCBS $36.15
  • Technical
  • Relative Strength Index (RSI)
  • STOK 55.63
  • MCBS 40.38
  • Support Level
  • STOK $12.25
  • MCBS $28.82
  • Resistance Level
  • STOK $14.99
  • MCBS $30.06
  • Average True Range (ATR)
  • STOK 0.83
  • MCBS 0.93
  • MACD
  • STOK -0.04
  • MCBS -0.19
  • Stochastic Oscillator
  • STOK 36.30
  • MCBS 6.40

About STOK Stoke Therapeutics Inc.

Stoke Therapeutics Inc is a biotechnology company dedicated to restoring protein expression by harnessing the body's potential with RNA medicine. Its proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to restore naturally-occurring protein levels selectively. Its first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome. The company provides early programs focused on multiple targets, including haploinsufficiency diseases of the central nervous system and eye, to up-regulate the protein expression of the underlying disease gene in a mutation-agnostic manner.

About MCBS MetroCity Bankshares Inc.

MetroCity Bankshares Inc is a holding company of its subsidiary Metro City Bank. It provides commercial banking services such as consumer and commercial checking accounts, savings accounts, certificates of deposits, commercial and consumer loans, money transfers and a variety of other banking services. The banks generate revenue from interest income. Its customers include small business owners, professionals, consumers, and real estate developers.

Share on Social Networks: